Biomarker Correlates of Radiologic Imaging
June 16, 2016 updated by: Washington University School of Medicine
The purpose of this study is to assemble a collection of urine and blood samples for the development and validation of biomarkers potentially useful in correlating or improving the diagnostic utility of abdominal imaging.
Study Overview
Status
Completed
Study Type
Observational
Enrollment (Actual)
751
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Missouri
-
St. Louis, Missouri, United States, 63110
- Washington University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Anyone undergoing an abdominal image, meeting eligibility criteria.
Description
Inclusion Criteria:
- 18 years and older
- Undergoing abdominal CT imaging (standard of care)
- Signed, informed consent
Exclusion Criteria:
- Patients on dialysis
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantitative measures
Time Frame: at enrollment
|
Confirm the ability of quantitative measure of AQP-1 and ADFP by ELISA from urine and blood samples to develop and validate an assay for patients with renal cancer.
|
at enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
differentiation of cancerous from non-cancerous renal mass
Time Frame: at analysis
|
Correct determination of tumor burden and differentiation of cancerous from non-cancerous renal mass.
|
at analysis
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2012
Primary Completion (Actual)
May 1, 2016
Study Completion (Actual)
May 1, 2016
Study Registration Dates
First Submitted
February 20, 2012
First Submitted That Met QC Criteria
February 23, 2012
First Posted (Estimate)
February 24, 2012
Study Record Updates
Last Update Posted (Estimate)
June 17, 2016
Last Update Submitted That Met QC Criteria
June 16, 2016
Last Verified
June 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 201201061
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal CT Imaging Performed as Standard of Care
-
AHS Cancer Control AlbertaCross Cancer InstituteWithdrawnLocally Advanced Cervical Cancer | Integrated MRI Based RT as Standard of Care